BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 34463768)

  • 21. The Importance of Endogenously Secreted GLP-1 and GIP for Postprandial Glucose Tolerance and β-Cell Function After Roux-en-Y Gastric Bypass and Sleeve Gastrectomy Surgery.
    Hindsø M; Hedbäck N; Svane MS; Møller A; Martinussen C; Jørgensen NB; Dirksen C; Gasbjerg LS; Kristiansen VB; Hartmann B; Rosenkilde MM; Holst JJ; Madsbad S; Bojsen-Møller KN
    Diabetes; 2023 Mar; 72(3):336-347. PubMed ID: 36478039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute Changes of Bile Acids and FGF19 After Sleeve Gastrectomy and Roux-en-Y Gastric Bypass.
    Chen Y; Lu J; Nemati R; Plank LD; Murphy R
    Obes Surg; 2019 Nov; 29(11):3605-3621. PubMed ID: 31273649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Comparative Study of the Effect of Gastric Bypass, Sleeve Gastrectomy, and Duodenal-Jejunal Bypass on Type-2 Diabetes in non-Obese Rats.
    Xu B; Yan X; Shao Y; Shen Q; Hua R; Ding R; Yao Q
    Obes Surg; 2015 Oct; 25(10):1966-75. PubMed ID: 26254879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Meta-Analysis of GLP-1 After Roux-En-Y Gastric Bypass: Impact of Surgical Technique and Measurement Strategy.
    Jirapinyo P; Jin DX; Qazi T; Mishra N; Thompson CC
    Obes Surg; 2018 Mar; 28(3):615-626. PubMed ID: 28871519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of Diabetes Remission and Micronutrient Deficiency in a Mildly Obese Diabetic Rat Model Undergoing SADI-S Versus RYGB.
    Wang T; Shen Y; Qiao Z; Wang Y; Zhang P; Yu B
    Obes Surg; 2019 Apr; 29(4):1174-1184. PubMed ID: 30610678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparing the Anti-diabetic Effect of Sleeve Gastrectomy with Transit Bipartition Against Sleeve Gastrectomy and Roux-en-Y Gastric Bypass Using a Diabetic Rodent Model.
    Liu P; Widjaja J; Dolo PR; Yao L; Hong J; Shao Y; Zhu X
    Obes Surg; 2021 May; 31(5):2203-2210. PubMed ID: 33507518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single-centre, triple-blinded, randomised, 1-year, parallel-group, superiority study to compare the effects of Roux-en-Y gastric bypass and sleeve gastrectomy on remission of type 2 diabetes and β-cell function in subjects with morbid obesity: a protocol for the Obesity
    Borgeraas H; Hjelmesæth J; Birkeland KI; Fatima F; Grimnes JO; Gulseth HL; Halvorsen E; Hertel JK; Hillestad TOW; Johnson LK; Karlsen TI; Kolotkin RL; Kvan NP; Lindberg M; Lorentzen J; Nordstrand N; Sandbu R; Seeberg KA; Seip B; Svanevik M; Valderhaug TG; Hofsø D
    BMJ Open; 2019 Jun; 9(6):e024573. PubMed ID: 31167860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GK-rats respond to gastric bypass surgery with improved glycemia despite unaffected insulin secretion and beta cell mass.
    Miskelly MG; Shcherbina L; Thorén Fischer AH; Abels M; Lindqvist A; Wierup N
    Peptides; 2021 Feb; 136():170445. PubMed ID: 33197511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Attenuated improvements in adiponectin and fat loss characterize type 2 diabetes non-remission status after bariatric surgery.
    Malin SK; Bena J; Abood B; Pothier CE; Bhatt DL; Nissen S; Brethauer SA; Schauer PR; Kirwan JP; Kashyap SR
    Diabetes Obes Metab; 2014 Dec; 16(12):1230-8. PubMed ID: 25132119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Similar Gut Hormone Secretions Two Years After One Anastomosis Gastric Bypass and Roux-en-Y Gastric Bypass: a Pilot Study.
    De Bandt D; Rives-Lange C; Frigout Y; Bergerot D; Blanchard A; Le Gall M; Lacorte JM; Chevallier JM; Czernichow S; Poghosyan T; Carette C; Le Beyec J
    Obes Surg; 2022 Mar; 32(3):757-762. PubMed ID: 34993850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone Mineral Density and Turnover After Sleeve Gastrectomy and Gastric Bypass: A Randomized Controlled Trial (Oseberg).
    Hofsø D; Hillestad TOW; Halvorsen E; Fatima F; Johnson LK; Lindberg M; Svanevik M; Sandbu R; Hjelmesæth J
    J Clin Endocrinol Metab; 2021 Jan; 106(2):501-511. PubMed ID: 33150385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive Value of Gut Peptides in T2D Remission: Randomized Controlled Trial Comparing Metabolic Gastric Bypass, Sleeve Gastrectomy and Greater Curvature Plication.
    Casajoana A; Pujol J; Garcia A; Elvira J; Virgili N; de Oca FJ; Duran X; Fernández-Veledo S; Vendrell J; Vilarrasa N
    Obes Surg; 2017 Sep; 27(9):2235-2245. PubMed ID: 28451931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Roux-en-Y gastric bypass compared with equivalent diet restriction: Mechanistic insights into diabetes remission.
    Pop LM; Mari A; Zhao TJ; Mitchell L; Burgess S; Li X; Adams-Huet B; Lingvay I
    Diabetes Obes Metab; 2018 Jul; 20(7):1710-1721. PubMed ID: 29532631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin sensitivity and secretion changes after gastric bypass in normotolerant and diabetic obese subjects.
    Salinari S; Bertuzzi A; Guidone C; Previti E; Rubino F; Mingrone G
    Ann Surg; 2013 Mar; 257(3):462-8. PubMed ID: 23388352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy on fasting gastrointestinal and pancreatic peptide hormones: A prospective nonrandomized trial.
    Yang J; Gao Z; Williams DB; Wang C; Lee S; Zhou X; Qiu P
    Surg Obes Relat Dis; 2018 Oct; 14(10):1521-1529. PubMed ID: 30449509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Roux en Y gastric bypass hypoglycemia resolves with gastric feeding or reversal: Confirming a non-pancreatic etiology.
    Davis DB; Khoraki J; Ziemelis M; Sirinvaravong S; Han JY; Campos GM
    Mol Metab; 2018 Mar; 9():15-27. PubMed ID: 29449181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigating Intestinal Glucagon After Roux-en-Y Gastric Bypass Surgery.
    Jorsal T; Wewer Albrechtsen NJ; Christensen MM; Mortensen B; Wandall E; Langholz E; Friis S; Worm D; Ørskov C; Støving RK; Andries A; Juhl CB; Sørensen F; Forman JL; Falkenhahn M; Musholt PB; Theis S; Larsen PJ; Holst JJ; Vrang N; Jelsing J; Vilsbøll T; Knop FK
    J Clin Endocrinol Metab; 2019 Dec; 104(12):6403-6416. PubMed ID: 31276156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exaggerated release and preserved insulinotropic action of glucagon-like peptide-1 underlie insulin hypersecretion in glucose-tolerant individuals after Roux-en-Y gastric bypass.
    Dirksen C; Bojsen-Møller KN; Jørgensen NB; Jacobsen SH; Kristiansen VB; Naver LS; Hansen DL; Worm D; Holst JJ; Madsbad S
    Diabetologia; 2013 Dec; 56(12):2679-87. PubMed ID: 24048673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Remission of type 2 diabetes after Roux-en-Y gastric bypass or sleeve gastrectomy is associated with a distinct glycemic profile.
    Jiménez A; Ceriello A; Casamitjana R; Flores L; Viaplana-Masclans J; Vidal J
    Ann Surg; 2015 Feb; 261(2):316-22. PubMed ID: 25569030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hormone changes and diabetes resolution after biliopancreatic diversion and laparoscopic sleeve gastrectomy: a comparative prospective study.
    Tsoli M; Chronaiou A; Kehagias I; Kalfarentzos F; Alexandrides TK
    Surg Obes Relat Dis; 2013; 9(5):667-77. PubMed ID: 23466015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.